# Trade Mark Journal No.2026/024 12 June 2026

## UK00004396672 3 June 2026 (44)

International priority date claimed: 9 February 2026 (United States of America) (99642833)

Class 44
  Providing information in the field of Alzheimer’s disease; Providing a website featuring information on managing behavioural symptoms associated with Alzheimer’s disease.

Axsome Therapeutics, Inc.

Representative: Keltie LLP